Mikusu India Private Ltd acquires 13,139 shares of Daikaffil Chemicals, raising stake to 49.62%

What Mikusu India disclosed

Mikusu India Private Limited submitted a disclosure to BSE on June 17, 2026 stating that it had acquired 13,139 equity shares of Daikaffil Chemicals India Ltd (BSE Scrip Code: 530825) on June 16, 2026. The acquisition was made through the open market and is reported under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

"We have acquired 13,139 Equity Shares on June 16, 2026 of Daikaffil Chemicals India Limited (Scrip Code: 530825) from Open Market (BSE)."

The filing was signed by Raghuram K. Shetty, Director of Mikusu India, and addressed to the exchange as required by the regulations.

Details of the acquisition

• Acquirer: Mikusu India Private Limited (promoter group of Daikaffil Chemicals).
• Target: Daikaffil Chemicals India Ltd.
• Number of shares acquired: 13,139.
• Mode of acquisition: Open‑market purchase on BSE.
• Date of acquisition: 16 June 2026.
• Share price: Not disclosed in the filing.
• Equity share capital of Daikaffil Chemicals: Rs 600 million, representing 60 million shares of Rs 10 each (unchanged before and after the transaction).
• Diluted share capital: Also Rs 600 million (60 million shares), indicating no convertible securities or warrants were involved.

Impact on promoter holding

Before the transaction, Mikusu India held 29,64,128 shares, which equated to 49.40% of both the total and diluted voting capital of Daikaffil Chemicals. After acquiring the additional 13,139 shares, its holding increased to 29,77,267 shares, raising its percentage to 49.62% of the total and diluted voting capital.

Why this matters for investors

The disclosure is a regulatory requirement whenever a promoter or any acquirer crosses certain share‑holding thresholds. Although the additional 13,139 shares represent a modest 0.22% of the total capital, the transaction nudges the promoter’s stake closer to the critical 50% mark. Crossing that threshold could trigger additional disclosure obligations, potential mandatory open‑offer requirements, or affect control dynamics, but the filing makes clear that the stake remains below 50%.

For shareholders, the key points are:

• No dilution: The share capital of Daikaffil Chemicals remains unchanged; the purchase was made from existing market supply.
• Regulatory compliance: By filing under Regulation 29(2), Mikusu India fulfills SEBI’s transparency rules, ensuring that the market is aware of changes in promoter holdings.
• Control considerations: While the promoter’s stake is now 49.62%, it does not constitute a majority. Investors should monitor any future acquisitions that could push the holding above 50%, as that may alter voting power and trigger additional regulatory steps.

Conclusion

Mikusu India Private Limited’s open‑market purchase of 13,139 Daikaffil Chemicals shares on 16 June 2026 increased its promoter stake from 49.40% to 49.62% of the company’s voting capital. The transaction was disclosed to BSE on 17 June 2026 under SEBI’s Regulation 29(2). While the acquisition does not change the company’s equity capital or confer majority control, it brings the promoter’s holding closer to the 50% threshold, a point that investors may wish to track in subsequent filings.